Business ❯ Healthcare ❯ Pharmaceutical Industry

Drug Development

Market Dynamics Investor Relations Cancer Medications Pfizer Products Innovative Therapies Antibodies Transparency in Drug Approval Clinical Trials Obesity Treatments Biosimilars GLP-1 Drugs Weight-Loss Treatments Market Competition GLP-1 Medicines Precision Medicine

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

Sales were led by injectable GLP-1 treatments that now face pressure from cheaper pills.

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy